Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib.
Saved in:
| Title: | Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib. |
|---|---|
| Authors: | Serrano, C.1,2 (AUTHOR) cserrano@vhio.net, Bauer, S.3 (AUTHOR), Gómez-Peregrina, D.2 (AUTHOR), Kang, Y.-K.4 (AUTHOR), Jones, R.L.5 (AUTHOR), Rutkowski, P.6 (AUTHOR), Mir, O.7 (AUTHOR), Heinrich, M.C.8 (AUTHOR), Tap, W.D.9 (AUTHOR), Newberry, K.10 (AUTHOR), Grassian, A.10 (AUTHOR), Shi, H.10 (AUTHOR), Bialick, S.11 (AUTHOR), Schöffski, P.12 (AUTHOR), Pantaleo, M.A.13 (AUTHOR), von Mehren, M.14 (AUTHOR), Trent, J.C.1,11 (AUTHOR), George, S.1,15 (AUTHOR) |
| Source: | Annals of Oncology. Jul2023, Vol. 34 Issue 7, p615-625. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2023.04.006 |
